added to a solution of 95.8 mg (0.25 mmol) (PhCN)2PdCl2 in 5 mL
of CH2Cl2. The resulting red–brown solution was stirred for 2 h
at room temperature, after which the colour changed to yellow.
The solvent was reduced to 5 mL, 20 mL of diethyl ether were
added and the resulting precipitate was collected by filtration.
After washing it twice with 10 mL of diethyl ether it was dried
in vacuum. Yield: 148 mg (89%), yellow solid. Anal. calcd. for
C30H21Cl2N2O3PPd·(CH3CN) (706.85): C, 54.38; H, 3.42; N, 5.94;
found: C, 54.48; H, 3.40; N, 5.81. IR (KBr, cm-1): 2963, 1509, 1261,
1221, 1183, 1091, 1068, 102◦6, 960, 927, 804.
Experimental
General
All reactions were carried out under an atmosphere of dinitrogen,
the solvents were dried before use. Chemicals were purchased from
Acros Organics, Sigma Aldrich and Strem chemicals. Compounds
1 and 3 were synthesised according to published procedures.8,15
The NMR spectra (Bruker DPX 400 and Bruker Avance 600),
the infrared spectra (JASCO FT/IR-6100), mass spectra (Bruker
ultraflex TOF/TOF), the X-ray structure analyses and elemental
analyses (Perkin-Elmer Elementar Analyser 2400 CHN) were
carried out at the Technischen Universita¨t Kaiserslautern.
1H NMR (600 MHz, 25 C, CD3CN): major isomer d 8.33 (d,
1H, 3JHH = 9.0 Hz, HAr), 8.29 (d, 1H, 3JHH = 9.0 Hz, HAr), 8.09–
0.16 (m*, 2H, HAr), 7.98–8.01 (m*, 2H, HAr), 7.93 (d, 1H, 3JHH
9.0 Hz, HAr), 7.90 (d, 1H, 3JHH = 9.0 Hz, HAr), 7.77 (t, 1H, 3JHH
=
=
Syntheses
7.8 Hz, HAr), 7.71–774 (m*, 1H, HAr), 7.64–7.70 (m*, 1H, HAr),
7.55–7.61 (m*, 1H, HAr), 7.51–7.55 (m*, 1H, HAr), 7.30–7.38 (m*,
3-(2-Hydroxyphenyl)(1-methyl)pyrazole (2).
A solution of
3
2H, HAr), 7.21–7.29 (m*, 2H, HAr), 6.66 (d, 1H, JHH = 2.6 Hz,
2.45 g (15.3 mmol) of 1 in 90 mL of dry THF was slowly treated
with 735 mg (30.6 mmol) of NaH at 0 ◦C. The mixture was warmed
up to room temperature and stirred for a further 2 h until hydrogen
evolution ceased. 950 mL (15.3 mmol) of methyliodide dissolved in
60 mL of dry THF were added dropwise and the resulting mixture
was stirred for 12 h at room temperature. The solvent was removed
in vacuum and 50 mL of a 1 M solution of NaHCO3 were added to
the residue. The aqueous solution was extracted three times with
50 mL of diethyl ether, the organic phases were combined, dried
over Na2SO4, and the solvent was evaporated. Yield: 2.39 g (90%),
pale yellow solid. 1H NMR (400 MHz, 25 ◦C, CDCl3): d 10.80 (br,
H4Pz), 4.57 (s, 3H, CH3); minor isomer d 8.09–0.16 (m*, 1H, HAr),
3
3
8.06 (d, 1H, JHH = 8.2 Hz, HAr), 8.03 (d, 1H, JHH = 2.6 Hz,
H5Pz), 7.98–8.01 (m*, 1H, HAr), 7.71–774 (m*, 2H, HAr), 7.64–
7.70 (m*, 2H, HAr), 7.55–7.61 (m*, 3H, HAr), 7.51–7.55 (m*, 1H,
HAr), 7.30–7.38 (m*, 2H, HAr), 7.21–7.29 (m*, 2H, HAr), 6.92 (d,
1H, 3JHH = 9.0 Hz, HAr), 6.78 (d, 1H, 3JHH = 2.6 Hz, H4Pz), 4.26 (s,
3H, CH3), signals assigned with an * are superimpos◦ed with those
1
of the other isomer. 31P{ H} NMR (242.94 MHz, 25 C, CD3CN):
d 99.2 (s), 97.6 (s).
Dichlorido[(g6 -para-cymene)(4-(2-(1-methylpyrazol-3-yl))phe-
nyloxy)-3,5-dioxa-4-phosphacyclohepta[2,1-a;3,4-a¢]dinaphtha-
lene]ruthenium(II) (6). A solution of 125 mg (0.25 mmol) of
3 in 10 mL of CH2Cl2 was added to a solution of 76.5 mg
3
4
1H, OH), 7.56 (dd, 1H, JHH = 7.8 Hz, JHH = 1.6 Hz), 7.39 (d,
1H, 3JHH = 2.4 Hz, H5Pz), 7.18–7.23 (m, 1H), 7.02 (dd, 1H, 3JHH
=
=
4
3
8.2 Hz, JHH = 1.2 Hz), 6.88–6.93 (m, 1H), 6.61 (d, 1H, JHH
2.4 Hz, H4Pz), 3.94 (s, 3H, CH3). 13C{ H} NMR (150.37 MHz,
25 ◦C, CDCl3) 155.9 (s, C–OH), 151.5 (s), 131.1 (s), 129.1 (s),
126.3 (s), 119.3 (s), 117.1 (s), 116.9 (s), 102.3 (s, C4Pz), 39.1 (s,
CH3).
1
6
(0.13 mmol) of [(h -para-cymene)RuCl2]2 in 5 mL of CH2Cl2.
The resulting red–brown solution was stirred for 24 h at room
temperature. The solvent was reduced to 5 mL and 20 mL of diethyl
ether were added. The red precipitate was collected by filtration,
washed twice with 10 mL of diethyl ether and recrystallized from
toluene/THF. Yield: 169 mg (0.21 mmol, 85%), red crystals. Anal.
calcd. for C40H35Cl2N2O3PRu (794.67): C, 60.46; H, 4.44; N, 3.53;
found: C, 59.97; H, 4.62; N, 3.37. IR (KBr, cm-1): 2962, 1590, 1505,
1464, 1323, 1226, 1189, 1070, 956, 912, 855, 838, 752, 696, 607,
(4-(2-(1-Methylpyrazol-3-yl))phenyloxy)-3,5-dioxa-4-phospha-
cyclohepta[2,1-a;3,4-a¢]dinaphthalene (4). 330 mg (1.9 mmol) of
2 and 280 mL (2 mmol) of NEt3 were dissolved in 20 mL of dry
THF. This solution was added dropwise to a solution of 700 mg
(2.0 mmol) of 3 in 20 mL of dry THF at 0 ◦C. The reaction mixture
was stirred for 2 h at 0 ◦C. After warming to room temperature, the
resulting suspension was stirred for a further 12 h. A precipitate
formed, which was filtered off, washed with THF and the filtrate
was evaporated in vacuum. The resulting white solid was washed
with 10 mL of diethyl ether and dried in vacuum. Yield: 650 mg
(70%). IR (KBr, cm-1): 2932, 2497, 1462, 1227, 1201, 1071, 953,
562. 1H NMR (600.13 MHz, 25◦C, CDCl3): d 7.97 (d, 1H, 3JHH
=
9.0 Hz), 7.92 (d, 1H, 3JHH = 8.8 Hz), 7.85–7.89 (m, 2H), 7.84 (d,
1H, 3JHH = 9.0 Hz), 7.75 (d, 1H, 3JHH = 8.3 Hz), 7.69 (d, 1H, 3JHH
=
7.4 Hz), 7.58 (d, 1H, 3JHH = 1.7 Hz), 7.41 (t, 1H, 3JHH = 7.5 Hz),
7.38 (t, 1H, 3JHH = 7.3 Hz), 7.32 (d, 1H, 3JHH = 8.8 Hz), 7.27 (d,
1H, 3JHH = 8.6 Hz), 7.19–7.24 (m, 3H), 7.15–7.19 (m, 1H), 7.13 (t,
886, 826, 768, 752, 555. H NMR (400 MHz, 25 ◦C, CDCl3):
d 7.85–8.08 (m, 5H), 7.16–7.62 (m, 12H), 6.63 (d, 1H, JHH
1
3
3
1H, JHH = 7.5 Hz), 6.80 (d, 1H, JHH = 1.9 Hz, H-4pz), 5.59 (d,
3
=
1H, 3JHH = 5.8 Hz, Hcym), 5.30 (d, 1H, 3JHH = 6.0 Hz, Hcym), 5.24
1.8 Hz, H4Pz), 3.99 (s, 3H, CH3). 13C{ H} NMR (150.37 MHz,
25◦C, CDCl3): d 148.9 (d, 2JP,C = 6.9 Hz), 148.0 (d, 2JP,C = 4.2 Hz),
147.4 (s), 147.2 (s), 132.9 (s), 132.7 (s), 131.7 (s), 131.2 (s), 130.8 (s),
130.5 (s), 129.8 (s), 129.2 (s), 128.7 (s), 128.4 (s), 128.3 (s), 127.1 (s),
127.0 (s), 126.4 (s), 126.2 (s), 125.2 (s), 125.0 (s), 124.7 (s), 124.4 (d,
2JP,C = 5.6 Hz), 122.9 (s), 121.82 (s), 121.77 (s), 120.8 (s), 120.7 (s),
1
3
3
(d, 1H, JHH = 6.0 Hz, Hcym), 5.00 (d, 1H, JHH = 5.8 Hz, Hcym),
4.08 (s, 3H, Mepz), 2.80 (sept, 1H, 3J = 6.9 Hz, CH(CH3)2), 1.97
3
(s, 1H, Mecym), 1.16 (d, 3H, CH(CH3)2), 1.11 (d, 3H, J 6.9 Hz,
◦
CH(CH3)2) 13C{ H} NMR (150.37 MHz, 25 C, CDCl3): d 149.6
1
2
2
(d, JPC = 8.3 Hz, CHar), 148.82 (d, JPC = 8.3 Hz, Car), 148.79
(d, 2JPC = 9.7 Hz, Car), 148.1 (s, Car), 133.0 (s, Car), 132.6 (s, Car),
132.0 (s, Car), 131.8 (s, Car), 131.2 (s, CarH), 130.3 (s, CarH), 130.0
(s, 2 ¥ CarH), 129.2 (s, CarH), 128.7 (s, CarH), 128.5 (s, CarH), 127.8
(s, CarH), 127.6 (s, CarH), 126.6 (s, CarH), 126.1 (s, CarH), 125.8
(s, CarH), 125.4 (s, CarH), 125.1 (s, CarH), 124.8 (s, Car), 124.5 (s,
CarH), 123.0 (s, Car), 122.6 (d, 3JPC = 2.8 Hz, CarH), 121.5 (s, CarH),
◦
107.3 (s, C4pz), 39.0 (s, CH3). 31P{ H} NMR (242.94 MHz, 25 C,
1
CDCl3): d 144.8.
Dichlorido[(4-(2-(1-methylpyrazol-3-yl))phenyloxy)-3,5-dioxa-
4-phosphacyclohepta[2,1-a;3,4-a¢]dinaphthalene]palladium(II) (5).
A solution of 125 mg (0.25 mmol) of 3 in 10 mL of CH2Cl2 was
This journal is
The Royal Society of Chemistry 2009
Dalton Trans., 2009, 4971–4977 | 4975
©